Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for DYN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 291.86M
March 31, 2026 214.90M
December 31, 2025 214.83M
September 30, 2025 175.28M
June 30, 2025 157.55M
March 31, 2025 52.10M
December 31, 2024 61.40M
September 30, 2024 63.30M
June 30, 2024 50.69M
March 31, 2024 44.22M
December 31, 2023 73.79M
September 30, 2023 53.21M
June 30, 2023 44.54M
March 31, 2023 46.71M
Date Value
December 31, 2022 53.96M
September 30, 2022 49.94M
June 30, 2022 52.97M
March 31, 2022 51.30M
December 31, 2021 57.47M
September 30, 2021 52.76M
June 30, 2021 14.55M
March 31, 2021 13.45M
December 31, 2020 10.97M
September 30, 2020 14.63M
June 30, 2020
March 31, 2020
December 31, 2019 2.40M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Vor Biopharma, Inc. 681.25M
Neurocrine Biosciences, Inc. 1.666B
Recursion Pharmaceuticals, Inc. 297.66M
Agenus, Inc. 378.54M
Amgen, Inc. 83.95B

Total Liabilities (Quarterly) Related Metrics